Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
American Journal of Hematology|January 26, 2022
COVID-19 vaccines and risks of hematological abnormalities: Nested case-control and self-controlled case series studyChor-Wing Sing, Casey Tze Lam Tang, Celine Sze Ling Chui, et al.
Emerging Microbes & Infections|May 3, 2023
Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case-control studyVincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 20, 2024
Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulationCuiling Wei, Vincent, Ka Chun Yan, et al.
NPJ Vaccines|December 15, 2022
Comparing hybrid and regular COVID-19 vaccine-induced immunity against the Omicron epidemicLei Huang, Francisco Tsz Tsun Lai, Vincent Ka Chun Yan, et al.
Plos Medicine|June 21, 2022
Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective studyCarlos King Ho Wong, Kristy Tsz Kwan Lau, Xi Xiong, et al.
Fungal Biology|May 5, 2019
Genomic analysis of the aggressive tree pathogen Ceratocystis albifundusMagriet A van der Nest, Emma T Steenkamp, Danielle Roodt, et al.
Plos One|July 28, 2025
Primary prevention cardiovascular disease risk prediction model for contemporary Chinese (1°P-CARDIAC): Model derivation and validation using a hybrid statistical and machine-learning approachYekai Zhou, Celia Jiaxi Lin, Qiuyan Yu, et al.
BMJ Public Health|February 28, 2025
Post-acute sequelae of hospitalised COVID-19 re-infection compared with hospitalised first-time infection: a population-based retrospective cohort study in Hong KongVincent Ka Chun Yan, Yin Zhang, Deliang Yang, et al.
The Lancet. Healthy Longevity|July 11, 2022
Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case seriesEric Yuk Fai Wan, Yuan Wang, Celine Sze Ling Chui, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 30, 2023
Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19-related deaths among people with multimorbidity: a cohort studyFrancisco Tsz Tsun Lai, Vincent Ka Chun Yan, Xuxiao Ye, et al.
Pageof 15